Association between individual KIRs and progression-free survival on univariate analysis
KIR gene . | Frequency in patient sample (%) . | P* . |
---|---|---|
KIR2DL1 | 171 (94) | .999 |
KIR2DL2 | 98 (53.6) | .97 |
KIR2DL3 | 151 (89) | .046† |
KIR2DL4 | 177 (97) | .999 |
KIR2DL5A (Alleles 001/005) | 55 (30) | .019† |
KIR2DL5B (Alleles 002-004, 006/007 | 45 (25) | .93 |
KIR3DL1 | 167 (92) | .999 |
KIR3DL2 | 177 (97) | .999 |
KIR3DL3 | 173 (95) | .999 |
KIR2DS1 | 51 (28) | .041† |
KIR2DS2 | 95 (52) | .32 |
KIR2DS3 | 47 (26) | .13 |
KIR2DS4 (alleles: 0010101-0010103, 00102/002) | 82 (45) | .38 |
KIR2DS4 (alleles 003/004/006/007) | 139 (76) | .385 |
KIR2DS5 | 55 (30) | .31 |
KIR3DS1 | 62 (34) | .01† |
KIR2DP1 | 180 (99) | .999 |
KIR3DP1 | 180 (99) | .999 |
KIR gene . | Frequency in patient sample (%) . | P* . |
---|---|---|
KIR2DL1 | 171 (94) | .999 |
KIR2DL2 | 98 (53.6) | .97 |
KIR2DL3 | 151 (89) | .046† |
KIR2DL4 | 177 (97) | .999 |
KIR2DL5A (Alleles 001/005) | 55 (30) | .019† |
KIR2DL5B (Alleles 002-004, 006/007 | 45 (25) | .93 |
KIR3DL1 | 167 (92) | .999 |
KIR3DL2 | 177 (97) | .999 |
KIR3DL3 | 173 (95) | .999 |
KIR2DS1 | 51 (28) | .041† |
KIR2DS2 | 95 (52) | .32 |
KIR2DS3 | 47 (26) | .13 |
KIR2DS4 (alleles: 0010101-0010103, 00102/002) | 82 (45) | .38 |
KIR2DS4 (alleles 003/004/006/007) | 139 (76) | .385 |
KIR2DS5 | 55 (30) | .31 |
KIR3DS1 | 62 (34) | .01† |
KIR2DP1 | 180 (99) | .999 |
KIR3DP1 | 180 (99) | .999 |